wu wu wu wu wu
the Brain and Behavior 3rd Edition
wu wu wu wu wu wu
By Meyer Nursing, Verified Chapters 1 - 20
wu wu wu wu wu wu wu
WWW.THENURSINGMASTERY.COM
Page1of247
u
w u
w u
w
,Chapter1.PrinciplesofPharmacology
u
w u
w u
w u
w
Chapter2.StructureandFunctionoftheNervousSystem
u
w u
w u
w u
w u
w u
w u
w u
w
Chapter3.ChemicalSignalingbyNeurotransmittersandHormones Chapter
w
u u
w w
u w
u u
w w
u u
w wu
wu 4. Methods of Research in Psychopharmacology
wu wu wu wu wu
Chapter5.Catecholamines
u
w u
w
Chapter6.Serotonin u
w u
w
Chapter7.Acetylcholine Chapter
u
w u
w wu
8.GlutamateandGABA
u
w u
w u
w u
w
Chapter9.DrugAbuseandAddiction Chapter
u
w u
w u
w u
w u
w wu
10.Alcohol
w
u u
w
Chapter11.TheOpioids
u
w u
w u
w
Chapter12.PsychomotorStimulants:Cocaine,Amphetamine, andRelatedDrugs
w
u u
w w
u w
u u
w wu w
u w
u
wu Chapter 13. Nicotine and Caffeine
wu wu wu wu
Chapter 14. Marijuana and the Cannabinoids Chapter
wu wu wu wu wu wu
15.Hallucinogens,PCP,andKetamine
u
w u
w u
w u
w u
w
Chapter16.Inhalants,GHB,andAnabolic-AndrogenicSteroids
w
u u
w w
u w
u w
u w
u
Chapter17.DisordersofAnxietyandImpulsivityandthefDrugsUsedtoTreatTheseDisorders
u
w u
w u
w u
w u
w u
w u
w u
w u
w u
w u
w u
w
wu Chapter 18. Affective Disorders: Antidepressants and Mood Stabilizers
wu wu wu wu wu wu wu
Chapter19.Schizophrenia: AntipsychoticDrugs
w
u u
w wu w
u
wu Chapter 20.Neurodegenerative Diseasesf
wu u
w wu
WWW.THENURSINGMASTERY.COM
Page2fof247
u
w u
w
, Chapter1:PrinciplesofPharmacology u
w u
w
MultipleChoice w
u
1.
w u w u refer(s)tospecificmolecularchangesthatoccurwhenadrugbindst oa particulartarg
u
w u
w u
w u
w u
w u
w u
w u
w u
w u
w
wu et site or receptor, while
wu wu wu wu
w u w u aretheresultingfwidespreadalterationsfinfunction. u
w u
w
a. Drugaction;therapeuticfeffects u
w u
w
b. Sideeffects;drugeffects u
w u
w
c. Therapeuticeffects; sidefeffects u
w wu
d. Drugfaction;drugeffects w
u u
w
ANSWER:fd
TextbookReference:Pharmacology: TheScienceofDrugfAction u
w u
w wu u
w w
u u
w
2. Afterdrugfadministrationhasoccurred,theamountofdruginthebloodthatisffreetofb ind
u
w w
u u
w u
w u
w w
u u
w u
w u
w u
w u
w u
w wu
atfspecificftargetfsites is referred to as
wu wu wu wu wu
a. thetherapeutic dose. wu
b. first-passeffects. w
u
c. bioavailability.
d. ED50.
ANSWER:fc
Textbook Reference: PharmacokineticfFactorsfDetermining DrugfAction
wu wu wu
3. The specific molecular changes that occurwhen a drug bindstoaparticulartarget sitefor
wu wu wu wu wu wu wu wu wu
wu receptorarereferredtofas w
u u
w
a. drugeffects.
WWW.THENURSINGMASTERY.COM
Page3fof247
u
w u
w
, b. drugfaction.
c. sideeffects.
u
w
d. placebofeffects.
ANSWER:fb
TextbookReference:Pharmacology: TheScienceofDrugfAction
u
w w
u wu u
w w
u u
w
4. Whichofthefollowingisfnotapossibleexplanationforplaceboeffects?
u
w u
w u
w u
w u
w u
w u
w
a. Pavlovianconditioning u
w
b. Geneticvariation
c. Drugcompetition
u
w
d. Expectationofoutcome u
w u
w
ANSWER:fc
TextbookReference:Pharmacology:TheScienceofDrugfAction
u
w w
u w
u u
w w
u u
w
WWW.THENURSINGMASTERY.COM
Page4fof247
u
w u
w